Learn More
Patent Registration No. : 10-2416861
[Review Number] Combination-2023-37-061
[Validity Period] 2026-10-23
This product is a "medical device."
Please read the precautions
and instructions carefully before use.
Please read the precautions
and instructions carefully before use.
[Review Number] Combination-2023-37-061
[Validity Period] 2026-10-23
This product is a "medical device."
Please read the precautions
and instructions carefully before use.
Please read the precautions
and instructions carefully before use.
What is MegaCARTI®?
It is a medical device
designed for the treatment
of knee cartilage defects.
designed for the treatment
of knee cartilage defects.
A medical device that helps
regenerate cartilage in areas
of knee joint cartilage defects.
regenerate cartilage in areas
of knee joint cartilage defects.
MegaCARTI® supports the regeneration of cartilage
in knee joint defect areas and treats cartilage damage.
in knee joint defect areas and treats cartilage damage.
MegaCARTI® has been clinically tested
and proven effective.
and proven effective.
Product Information
| Product Name | MegaCARTI® |
|---|---|
| Main Ingredient | Allogenic Cartilage |
| Purpose of Use | Prevents disease progression, supports cartilage regeneration, and is used for treating cartilage defects. |
| Target Patients |
|
[Source]Ministry of Health and Welfare Evaluation – Designated as an Innovative Medical Technology (No. 2023-129, July 11, 2023)
Effects of MEGACATI®
EFFICACY 1
Through the MOCART Score,
significant cartilage regeneration effects
were confirmed even in patients over the age of 50.
significant cartilage regeneration effects
were confirmed even in patients over the age of 50.
The MOCART Score is an MRI-based evaluation criterion that compares the degree of cartilage regeneration.
EFFICACY 2
Through the MOCART Score, significant cartilage regeneration effects were confirmed in ICRS Grade 3 and 4 patients.
ICRS Grade is a classification system that evaluates the severity of knee cartilage damage, ranging from Grade 0 to 4, with higher numbers indicating more severe damage.
[Source] Kwangho Chung(2023), Particulated Costal Allocartilage With
Microfracture Versus Microfracture Alone for Knee Cartilage Defects:
A Multicenter, Prospective, Randomized, Participantand Rater-Blinded Study, The Orthopaedic Journal of Sports Medicine,11(7),6-11
A Multicenter, Prospective, Randomized, Participantand Rater-Blinded Study, The Orthopaedic Journal of Sports Medicine,11(7),6-11
Journal
Conferences & Research Papers
